Target intelligence / Profile preview

Macula

Molecular classification
Other
01

Overview

The **macula** (also known as the macula lutea) is not a molecule, receptor, or protein but rather an anatomical region of the retina in the eye. It is responsible for central vision and high-acuity visual processing. The macula contains a high density of photoreceptor cells—primarily cones—that are essential for tasks requiring detailed vision such as reading and recognizing faces[3]. Diseases affecting this area, most notably age-related macular degeneration (AMD), lead to loss of central vision due to damage or death of these photoreceptors and supporting retinal pigment epithelium cells[3][4][5][6]. While many molecular targets within the retina and retinal pigment epithelium are under investigation for therapeutic intervention in AMD (such as IRAK-M, TIMP3, WARS1), "macula" itself does not refer to a specific druggable target or molecular entity[2][5][6]. Because "macula" refers to an anatomical structure rather than a discrete molecule or receptor, it is not considered a therapeutic target by standard definitions. If you are seeking information on specific molecular targets relevant to diseases of the macula—such as proteins implicated in AMD pathogenesis—please specify those molecules by name (e.g., complement factor H, VEGF receptor)[2][5][6].

Other names
MaculaMacula luteaMacular region
02

Biological functions

Central visionHigh-acuity visual processing
03

Disease associations

Age-related macular degeneration (AMD)

Beyond the preview

Go deeper on Macula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call